Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands"
- PMID: 35838877
- PMCID: PMC9284101
- DOI: 10.1007/s40264-022-01207-x
Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands"
Conflict of interest statement
The authors AK and FH declare no relevant conflicts of interest.
Comment on
-
Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.Drug Saf. 2022 Apr;45(4):319-331. doi: 10.1007/s40264-022-01151-w. Epub 2022 Mar 21. Drug Saf. 2022. PMID: 35314943 Free PMC article.
-
Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".Drug Saf. 2022 Aug;45(8):923. doi: 10.1007/s40264-022-01205-z. Epub 2022 Jul 15. Drug Saf. 2022. PMID: 35838876 Free PMC article. No abstract available.
References
-
- World Health Organization. Adverse events following immunization (AEFI) https://www.who.int/teams/regulation-prequalification/regulation-and-saf.... Accessed 19 Apr 2022.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
